Classification Committee
Members (2012-2013)
| Theresa Ormiston (Managing
Chair) |
IMS - UK |
| Anthony Palkovic (Co-Chair PBIRG) |
Pfizer - USA |
| Alex Adams (Co-Chair EphMRA) |
Novartis - Switzerland |
| Gregory Senac |
Pierre-Fabre Medicament - France |
| Majd Alamad |
Takeda - Switzerland |
| Davyd Freeman |
Shire - Switzerland |
| Philip Reynolds |
IMS - UK |
| Etsuyo Ogawa |
Bayer, Japan - Special Japanese Liaison
Associate |
Remit
- Developing and improving the Anatomical Classification system
in line with changes in pharmaceutical markets.
- Ensuring the correct classification of products used in IMS
services
- Liaising with the WHO to ensure the two systems converge rather
than diverge
- Interpreting and discussing suggested changes and acting
accordingly
- Reclassifying products at year-end to be in line with the new
classification
- Communicating changes to PBIRG (minutes, exchange of
information, etc.)
- Conducting census of EphMRA & PBIRG on new, requested
changes to the system
- The Committee reconciles differences of opinions in the
classification of products
NEW!! Apprentice Opportunity on Classification
Committee (for pharma members) -
read on....
and
Application Form
Comparison of the WHO ATC
Classification 2012
Who we are,
What we Do 2012 Brochure